Neuralink Rival Paradromics Cleared to Start Speech Trial

Neuralink rival Paradromics cleared to start speech trial

Brain computer interface developer Paradromics has been cleared to start a US clinical trial of its Connexus implant for speech restoration.

FDA approves Paradromics’ brain-computer interface trial for speech restoration

Paradromics announced Thursday that the Food and Drug Administration approved a clinical study to evaluate whether the company’s brain-computer interface for speech restoration is safe and capable of providing the ability to communicate via text or synthesized speech to someone with paralysis.  The Austin-based company is one of a handful of startups — including Elon Musk’s Neuralink, Synchron, and Precision Neuroscience, among others — that hav…

Paradromics Gets FDA Approval to Trial Its Brain Implant in People

The Austin-based startup will test its high-bandwidth device to help restore speech in people with extremely limited movement.

Speech-restoring brain chip gets FDA approval for human trial

Paradromics gets FDA approval for its Connexus BCI human trial, aiming to restore speech and computer control for people with severe paralysis.